Kestra Medical Technologies, Ltd. Interest Expense Nonoperating
Kestra Medical Technologies, Ltd. (KMTS) reported Interest Expense Nonoperating of $1.93 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. interest expense nonoperating for the quarter ending 2026-07-31 was $1.93M, a 0.89% increase year-over-year.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for the quarter ending 2026-04-30 was $1.84M, a 4.77% increase year-over-year.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for the quarter ending 2026-01-31 was $1.89M, a 5.89% increase year-over-year.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for the quarter ending 2025-10-31 was $1.90M, a 17.95% decline year-over-year.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for fiscal 2026 was $7.55M, a 2.43% decline from fiscal 2025.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for fiscal 2025 was $7.73M, a 24.14% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. interest expense nonoperating for fiscal 2024 was $6.23M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-07-31 | $1.93M 10-Q · filed 2026-09-14 | $3.77M derived: sum of 2 quarters · filed 2026-09-14 | $5.66M derived: sum of 3 quarters · filed 2026-09-14 | $7.56M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $3.73M derived: sum of 2 quarters · filed 2026-07-14 | $5.63M derived: sum of 3 quarters · filed 2026-07-14 | $7.55M 10-K · filed 2026-07-14 |
| 2026-01-31 | $1.89M 10-Q · filed 2026-03-17 | $3.79M derived: sum of 2 quarters · filed 2026-03-17 | $5.70M 10-Q · filed 2026-03-17 | $7.46M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $1.90M 10-Q · filed 2025-12-11 | $3.81M 10-Q · filed 2025-12-11 | $5.57M derived: sum of 3 quarters · filed 2026-09-14 | $7.36M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $1.91M 10-Q · filed 2026-09-14 | $3.67M derived: sum of 2 quarters · filed 2026-09-14 | $5.46M derived: sum of 3 quarters · filed 2026-09-14 | $7.77M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $3.54M derived: sum of 2 quarters · filed 2026-07-14 | $5.86M derived: sum of 3 quarters · filed 2026-07-14 | $7.73M 10-K · filed 2026-07-14 |
| 2025-01-31 | $1.78M 10-Q · filed 2026-03-17 | $4.10M derived: sum of 2 quarters · filed 2026-03-17 | $5.97M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $2.32M 10-Q · filed 2025-12-11 | $4.19M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $1.87M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $6.23M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |